Evry, FranceSep 2024
Abolis Biotechnologies raised €35M in a funding round in Sep 2024. The company is based in Evry, France. Investors in the round: BOLD, Clay Capital, DeepTech & Climate Fonds and 3 others. Data as of Nov 2026.
Amount raised
€35M
€35,000,000
Native amount
35,000,000 EUR
Stage
Other
funding round
Investors
6
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €35M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
6 namedDate
Sep 2024
Round type
funding round
Amount (EUR)
€35M
Other rounds
same companyThis is the company's only recorded round.